top of page

Margo Jacobsen

Joined HSyE: March 2016
Hometown: San Juan Capistrano, CA
Education:MS, Industrial Engineering, Northeastern University (Expected May 2018);

BA, Anthropology, Cornell University (2013)

Research Interests: Access to care, economic health policy, HIV, global health

Hobbies: Traveling, Painting, Sewing

  • LinkedIn Clean Grey

Margo Jacobsen is a Research Project Manager at HSyE that oversees a portfolio of work on the opioid epidemic, infection surveillance using statistical process control, and collaborative research on graduate medical education, access to care, and patient safety. Prior to coming to Northeastern, she worked at the Medical Practice Evaluation Center at Massachusetts General Hospital conducting economic health policy research on HIV and tuberculosis. She also has over three years of experience as a non-profit grant writer for a Massachusetts-based organization that provides specialized services to women survivors of sex trafficking in Massachusetts. Margo received her undergraduate degree from Cornell University, where she majored in Anthropology and minored in Global Health. She is currently pursuing her MS in Industrial Engineering at Northeastern University.

Project Involvement at HSyE

Surgical Site Infection Prediction-- Statistical Process Control

NSF – Development and Validation of Analytic Spatial-Temporal Models to Help Study and Mitigate the National Opioid-Heroin Co-Epidemic

Systems Analysis of Graduate Medical Education Processes

Timeliness of Access to Cancer Care

New Methods for Reducing Adverse Events and Harmful Overuse

Selected Publications



Jacobsen MM, Walensky RW. Modeling and Cost-Effectiveness in HIV Prevention. Curr HIV/AIDS Rep. 2016.13(1):65-75.


Walensky RW, Jacobsen MM, Bekker LG, Parker RA, Wood R, Resch SC, Horstman NK, Freedberg KA, Paltiel AD. Potential Clinical and Economic Value of Long-Acting Pre-Exposure Prophylaxis for South African Women at High-Risk for HIV Infection. J Infect Dis. 2016. 213(10);1523-31.


Bassett IV, Coleman SM, Giddy J, Bogart LM, Chaisson CE, Ross D, Jacobsen MM, Robine M, Govender T, Freedberg KA, Katz JN, Walensky RP, Losina E. Sizanani: A Randomized Trial of Health System Navigators to Improve Linkage to HIV and TB Care in South Africa. J Acquir Immune Defic Syndr. 2016. 73(2):154-60.


Jacobsen MM, Silverstein SC, Quinn M, Waterston LB, Thomas CA, Benneyan JC, Han PKJ. Timeliness of Access to Lung Cancer Diagnosis and Treatment: A Scoping Literature Review. 2017. Under Review.


Musdal H, Cyr ME, Jacobsen MM, Benneyan JC. Model-based Analysis of Lyme Disease Testing and Treatment Practices: Misdiagnoses, Costs, and Antibiotic Overuse. 2017. Under Review.




Ilies I, Anderson DJ, Jacobsen MM, Salem J, Baker AW, Benneyan JC. Retrospective Optimization of Statistical Process Control (SPC) Charts to Detect Clinically-Relevant Increases in Surgical Site Infection (SSI) Rates. ID Week. San Diego, CA.October 4-8, 2017. Abstract #63986.


Cyr ME, Jacobsen MM, Benneyan JC. The Costs and Consequences of Poor Access to Care. SHS Healthcare Systems Process Improvement Conference. Orlando, FL. March 1-3, 2017. Abstract #2119.


Benneyan JC, Jacobsen MM, Ergai A, Gurney R, Silverstein SC, Han PKJ, Waterston L, Van der Kloot T, Bing-You R, Bates PW. Systems Engineering Collaboration to Analyze Internal Medicine Residency. Society of General Internal Medical Annual Meeting. Washington, D.C. April 19-22, 2017. Abstract #2698159.


Oudiz R, Mathai S, White R, Jacobsen M, Weycker D, Burger C. Cost of First-Line Treatment of Pulmonary Arterial Hypertension with Ambrisentan Plus Tadalafil. AMCP Managed Care & Specialty Pharmacy Annual Meeting. San Francisco, CA. April 19-22, 2016. Abstract #I16.


Oudiz RJ, Mathai SC, White RJ, Jacobsen MM, Weycker D, Burger CD. Cost Consequences of Initial Combination Treatment of PAH with Ambrisentan and Tadalafil. American Thoracic Society 2016. San Francisco, CA. May 13-18, 2016. Abstract #A2953.

bottom of page